首页> 外国专利> polypeptide, polynucleotide, vector, composition, use of peptide or polypeptide, methods of treating or ameliorating sepsis, septic shock or conditions similar to sepsis in an individual, and screening compounds or compositions for treating sepsis, septic shock or the like sepsis and vector use

polypeptide, polynucleotide, vector, composition, use of peptide or polypeptide, methods of treating or ameliorating sepsis, septic shock or conditions similar to sepsis in an individual, and screening compounds or compositions for treating sepsis, septic shock or the like sepsis and vector use

机译:多肽,多核苷酸,载体,肽或多肽的组合物,肽或多肽的用途,治疗或改善败血症的方法,败血性休克或类似于个体的败血症的条件,以及筛选用于治疗败血症,败血性休克等脓毒症和载体的化合物或组合物

摘要

Polypeptide, polynucleotide, vector, composition, use of peptide or polypeptide, methods of treatment or improvement of sepsis, septic shock, or conditions similar to sepsis in a sepsis or combination with sepsis or sepsis SEPSE, AND, USE OF VECTOR. A polypeptide comprising one or more CDR2 or CDR3-derived sequences of a TREM-1 protein, characterized by the ability to treat, ameliorate, or reduce the symptoms of sepsis, septic shock or sepsis-like conditions.
机译:多肽,多核苷酸,载体,肽或多肽的组成,用途或败血症的治疗或改善方法,败血症性休克或与败血症或败血症或败血症合并的脓毒症相似的败血症或脓毒症或脓毒症的患者,以及使用VECTOR。一种包含TREM-1蛋白的一个或多个CDR2或CDR3衍生序列的多肽,其特征在于能够治疗,改善或减轻败血症,败血性休克或败血症样症状的症状。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号